Health CanadaType II
Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tablets
Published: June 10, 2025Recall ID: 77577Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
Jamp-Hydralazine tablet
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77577 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/jamp-hydralazine-tablet-affected-lot-may-contain-jamp-hydralazine-10-mg-tablets |
| Issue | Product safety |
| Title | Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tablets |
| Product | Jamp-Hydralazine tablet |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-06-10 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |